Rashmikant Patel Samir's most recent trade in Akari Therapeutics Plc - ADR was a trade of 15,466 American Depositary Shares representing Ordinary Shares done at an average price of $0.0 . Disclosure was reported to the exchange on July 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2026 | 15,466 | 92,442 (0%) | 0% | 0.0 | 6 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2026 | 15,466 | 0 | - | - | Pre-Funded Warrant to purchase ADSs | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2026 | 5,799 | 0 | - | - | Pre-Funded Warrant to purchase ADSs | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2026 | 5,799 | 98,241 (0%) | 0% | 0.0 | 2 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.00 per share. | 07 Jul 2026 | 1,209 | 76,976 (0%) | 0% | 8 | 9,672 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2026 | 1,209 | 0 | - | - | Pre-Funded Warrant to purchase American Depositary Shares | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Dec 2025 | 618,658 | 618,658 | - | - | Pre-Funded Warrants to purchase ADRs | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Dec 2025 | 618,658 | 618,658 | - | - | Warrants to purchase American Depositary Shares ("ADRs") | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Dec 2025 | 231,997 | 231,997 | - | - | Warrants to purchase ADRs | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Dec 2025 | 231,997 | 231,997 | - | - | Pre-Funded Warrants to purchase ADRs | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 06 Mar 2025 | 406,250 | 3,031,005 (0%) | 0% | 1.1 | 455,000 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 406,250 | 406,250 | - | - | Series A Warrants (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 406,250 | 406,250 | - | - | Series B Warrants (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 152,672,000 | 152,672,000 | - | - | Stock Option (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 208,000 | 5,249,511,500 (344%) | 0% | 0.0 | 125 | Ordinary Shares, par value $0.0001 per share |
| Akari Therapeutics PLC (ADR) | Rashmikant Patel Samir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2024 | 3,200,000 | 5,248,903,500 (344%) | 0% | 0.0 | 1,600 | Ordinary Shares, par value $0.0001 per share |
| Akari Therapeutics PLC (ADR) | Rashmikant Patel Samir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2024 | 400,000 | 5,249,303,500 (344%) | 0% | 0.0 | 200 | Ordinary Shares, par value $0.0001 per share |
| Akari Therapeutics PLC (ADR) | Samir Patel Rashmikant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 7,500,000 | 5,245,703,500 (343%) | 0% | 0.0 | 3,750 | Ordinary Shares, par value $0.0001 per share |
| Akari Therapeutics PLC (ADR) | Samir Patel Rashmikant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 1,400,000 | 5,238,203,500 (343%) | 0% | 0.0 | 700 | Ordinary Shares, par value $0.0001 per share |
| Akari Therapeutics PLC (ADR) | Rashmikant Patel Samir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 1,400,000 | 5,236,803,500 (343%) | 0% | 0.0 | 700 | Ordinary Shares, par value $0.0001 per share |
| Akari Therapeutics PLC (ADR) | Patel Samir Rashmikant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2024 | 419,286,000 | 5,235,403,500 (343%) | 27% | 0.0 | 503,143 | Ordinary Shares, par value $0.0001 per share |
| Akari Therapeutics PLC (ADR) | Patel Samir Rashmikant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2024 | 419,286,000 | 419,286,000 | - | - | Warrants (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2024 | 162,604,000 | 162,604,000 | - | - | Stock Option (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 1,404,622,000 | 4,816,117,500 (315%) | 92% | - | Ordinary Shares, par value $0.0001 per share | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2024 | 79,684,000 | 79,684,000 | - | - | Stock Option (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 175,080,000 | 175,080,000 | - | - | Stock Option (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 91,396,000 | 91,396,000 (5%) | 5% | 0 | Ordinary Shares, par value $0.0001 per share | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,326,258,000 | 1,326,258,000 | - | - | Warrants (Right to Buy) | |
| Akari Therapeutics PLC (ADR) | Samir Rashmikant Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,326,258,000 | 3,411,495,500 (223%) | 86% | 0.0 | 1,193,632 | Ordinary Shares, par value $0.0001 per share |